Artykuły w Czytelni Medycznej o SARS-CoV-2/Covid-19

Chcesz wydać pracę doktorską, habilitacyjną czy monografię? Zrób to w Wydawnictwie Borgis – jednym z najbardziej uznanych w Polsce wydawców książek i czasopism medycznych. W ramach współpracy otrzymasz pełne wsparcie w przygotowaniu książki – przede wszystkim korektę, skład, projekt graficzny okładki oraz profesjonalny druk. Wydawnictwo zapewnia szybkie terminy publikacji oraz doskonałą atmosferę współpracy z wysoko wykwalifikowanymi redaktorami, korektorami i specjalistami od składu. Oferuje także tłumaczenia artykułów naukowych, skanowanie materiałów potrzebnych do wydania książki oraz kompletowanie dorobku naukowego.

Poniżej zamieściliśmy fragment artykułu. Informacja nt. dostępu do pełnej treści artykułu tutaj
© Borgis - New Medicine 3/2010, s. 84-87
*Małgorzata Tokarska-Rodak1, Hanna Fota-Markowska2, Maria Kozioł-Montewka1, Filip Śmiechowicz2, Roma Modrzewska2
The detection of specific antibodies against B. burgdorferi s.s., B. afzelii , B. garinii, and B. spielmani antigens in patients with Lyme disease in eastern Poland
1Department of Medical Microbiology, Medical University, Poland
Head of Department of Medical Microbiology: prof. dr hab. Maria Kozioł-Montewka
2Department of Infectious Diseases, Medical University, Lublin, Poland
Head of Department of Infectious Diseases: prof. dr hab. n. med. Roma Modrzewska
Summary
Aim. The purpose of the investigation was to determine the presence of antibodies for B. burgdorferi s.s., B. afzelii , B. garinii , and B. spielmani in persons with Lyme disease from the Lubelski region (eastern Poland) in the aspect of existing disease symptoms.
Materials and methods. The study was conducted in a group of 45 patients with the second stage of Lyme disease hospitalized in 2007-2008. The presence of anti- B. burgdorferi s.l. antibodies IgM and IgG was determined in the patients' serum (Western blot test, Mikrogen).
Results. The antibodies (IgM/IgG) for four gene-species, B. burgdorferi s.s., B. afzelii , B. garinii , and B. spielmani, were present in 39 patients from 45 tested. The presence of IgM anti-OspC antibodies for 1 gene-species, B. spielmani, was found only in 1 person.
Symptoms involving bone/joint structure in the tested group of patients were present among 41 persons, and symptoms of muscle pain among 21. Patients also complained of headaches and attention deficit disorder (6 persons). Erythema migrans appeared in 2 persons.
Conclusions. The results of the study suggest the possibility of co-infections with several gene-species of B. burgdorferi s.l. evidenced by the presence of IgM antibodies to OspC of B. burgdorferi s.s., B. afzelii , B. garinii , and B. spielmani.The detection of antibodies directed against specific B. spielmani antigens suggests that this microorganism may be responsible for triggering Lyme disease both as a single etiologic agent and in co-infection with other Borrelia gene-species. A relation between the types of symptoms present among patients with Lyme disease and gene-species responsible for causing diseases was not found.
Introduction
The complex of Borrelia burgdorferi sensu lato encompasses at least 12 species: B. burgdorferi sensu stricto, B. garinii , B. afzelii , B. spielmani , B. valaisiana , B. lusitaniae , B. japonica , B. andersonii , B. tanukii , B. turdae , B. bissettii and B. sinica. The main pathogenic genomic species responsible for human Lyme disease in Central Europe and Eastern Europe are: Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii. However, the DNA of B. valaisiana, B. lusitaniae , and B. spielmani detected in samples of human origin or the spirochetes were isolated from patients with symptoms of Lyme disease (1, 2). The genetic variability of Borrelia species has a considerable impact on the pathogenesis and clinical picture (3, 4, 5, 6). The heterogeneous clinical manifestation observed in Lyme disease inclined researchers to analyze the relation of infection by particular gene-species of B. burgdorferi s.l. with clinical symptoms that appeared. Borrelia afzelii seems to be associated with acrodermatitis chronica atrophicans (ACA) and with borrelia lymphocytoma, B. garinii with neuroborreliosis and B. burgdorferi s.s with arthritis (2, 3). Patients with EM reveal infection with all three gene-species: B. burgdorferi s.s., Borrelia afzelii and Borrelia garinii. Examinations of cerebrospinal fluid in patients with neurological symptoms of Lyme disease have revealed the possibility of a relation of neuroborreliosis with the presence of each of those three gene-species (7). DNA of B. valaisiana was detected in the cerebrospinal fluid of a patient with chronic neuroborreliosis in Greece and in a patient with erythema migrans. B. lusitaniae was isolated from a patient with suspected Lyme disease in Portugal (3). A direct association of skin changes of erythema migrans (EM) type with an infection of B. spielmani was revealed in some European countries (Netherlands, Germany, Hungary, Slovenia). Thus, the association of these gene-species with Lyme disease has been proven (8). The number of substantiated infections of B. spielmani is still insufficient in order to present the differences in Lyme disease manifestations caused by B. spielmani in comparison with Lyme disease caused by other gene-species. To date, an investigation which could explicitly affirm the relation of Lyme infection morbidity with infection by B. spielmani within Poland has not been performed yet.
Aim of the study
The aim of the study was to determine the presence of antibodies for four gene-species of Borrelia burgdorferi s.l. - B. burgdorferi s.s., B. afzelii , B. garinii , and B. spielmani - in persons with Lyme disease from the Lubelski region (eastern Poland) in the aspect of existing disease symptoms.
Materials and methods
The study was conducted in a group of 45 patients: 23 men (age 20-66 yrs) and 22 women (age 20-60 yrs) with the second stage of Lyme disease hospitalized in the Department of Infectious Diseases, Medical University of Lublin in 2007-2008.
The study group involved patients demonstrating manifestations of joint involvement including arthralgia and/or arthritis treated symptomatically and receiving etiotropic antimicrobial therapy. The diagnosis of borreliosis was established on the basis of the patient's medical history, physical examination, clinical picture, and serologic investigation (ELISA and Western blot).
Testing for antibodies IgG and IgM to Borrelia burgdorferi sensu lato was performed using the Western blot test (recomLine Borrelia IgG and IgM, Mikrogen) which included antigens for IgM and IgG: OspC ( B. burgdorferi s.s., B. afzelii , B. garinii , B. spielmani), p18 ( B. burgdorferi s.s., B. afzelii , B. garinii , B. spielmani), VlsE, p100, p58, p41, p39, OspA. The presence of anti- B. burgdorferi sensu lato antibodies IgM and IgG was determined in the patients' serum.
Results
IgM antibodies alone against specific Borrelia burgdorferi s.l. antigens were detected in 17 of 45 patients (38%). The IgM antibodies anti-OspC and anti-p18 B. burgdorferi s.l. were observed with varying frequency in this group. Table 1 shows IgM antibodies anti-OspC and anti-p18 B. burgdorferi s.s., B. afzelii , B. garinii, and B. spielmani in persons with Lyme disease.
Table 1. IgM antibodies against B. burgdorferi s.l. specific antigens in patients with Lyme borreliosis.
N=17Presence of IgM anti-B. burgdorferi s.l. antigens
anti-OspCanti-p-18anti-p41
12b, a, g, s-+
1b, a, g, sb, s+
2a, g, s-+
1b, a, s-+
1a, s-+
b – Borrelia burgdorferi sensu stricto
a – Borrelia afzelii
g – Borrelia garinii
s – Borrelia spielmani
+ presence of antibodies
IgM and IgG antibodies against specific Borrelia burgdorferi s.l. antigens were detected in 28 of 45 patients (62%). Table 2 shows IgM and IgG antibodies anti-OspC and anti-p18 for B. burgdorferi s.s., B. afzelii , B. garinii , and B. spielmani in persons with Lyme borreliosis.
Table 2. IgG antibodies against specific Borrelia burgdorferi s.l. antigens in patients with Lyme borreliosis.
N=28Presence of IgM anti-B. burgdorferi s.l. antigensPresence of IgG anti-B. burgdorferi s.l. antigensPresence of IgM/IgG
anti-OspCanti-p-18anti-OspCanti-p18against other specific antigenic B. burgdorferi s.l protein
8b, a, g, s-b, a, g, s-+
4b, a, g, s---+
1b, a, g, s-aa+
3b, a, g, s--a+
1b, a, g, s---+
1b, a, g, sb, g, sa, g1, g2+
1b, a, g, s-b, a-+
1b, a, g, ssb, a, g, s-+
1b, a, g, ss-g2+
1b, a, g, s-g, s-+
1b, a, g, s-b-+
1b, a, g, s-b, g, s-+
1a, ss-a+
1b, a, g, s-ab+
1s---+
1b, a, ssg, s-+
b – Borrelia burgdorferi sensu stricto
a – Borrelia afzelii
g – Borrelia garinii
s – Borrelia spielmani
+ presence of antibodies

Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.

Płatny dostęp tylko do jednego, POWYŻSZEGO artykułu w Czytelni Medycznej
(uzyskany kod musi być wprowadzony na stronie artykułu, do którego został wykupiony)

Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu wraz z piśmiennictwem , należy wprowadzić kod:

Kod (cena 19 zł za 7 dni dostępu) mogą Państwo uzyskać, przechodząc na tę stronę.
Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.

 

 

Płatny dostęp do wszystkich zasobów Czytelni Medycznej

Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu wraz z piśmiennictwem oraz WSZYSTKICH około 7000 artykułów Czytelni, należy wprowadzić kod:

Kod (cena 49 zł za 30 dni dostępu) mogą Państwo uzyskać, przechodząc na tę stronę.
Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.

otrzymano: 2010-07-28
zaakceptowano do druku: 2010-08-31

Adres do korespondencji:
*Małgorzata Tokarska-Rodak
Department of Medical Microbiology, Medical University of Lublin
Chodźki Str. 1, 20-093 Lublin, Poland
phone/fax: +48 81 7423781
e-mail: rodak.malgorzata@gmail.com

New Medicine 3/2010
Strona internetowa czasopisma New Medicine